AUTHOR=Kawahara Hikaru , Okada Etsuko , Sawada Yu 

TITLE=Rechallenge of brentuximab vedotin was effective for refractory mycosis fungoides: a case report

JOURNAL=Journal of Cutaneous Immunology and Allergy

VOLUME=7

YEAR=2024

URL=https://www.frontierspartnerships.org/journals/journal-of-cutaneous-immunology-and-allergy/articles/10.3389/jcia.2024.12474

DOI=10.3389/jcia.2024.12474

ISSN=2574-4593

ABSTRACT=<p>Mycosis fungoides (MF) is a type of primary cutaneous T-cell lymphoma. The anti-cluster of differentiation (CD) 30 antibody agent, brentuximab vedotin (BV), has recently been developed for specific targets against CD30-expressed tumor cells with high efficacy against various lymphomas. Herein, we present a case of marginally CD30-expressed MF successfully treated with BV rechallenge.</p>